Experience

Cardiokol

• Israel
• Health and Human Services
• 1 - 100 Employee

• CEO and Board Member

  • Mar 2021 - 2 years 10 months

  Harnessing voice paired with Artificial Intelligence and Machine Learning to detect and monitor dangerous heart arrhythmias.  Raising funds.  GTM Strategy & Implementation.  Strategic Collaborations.  Determining Regulatory Pathways.

• Chief Executive Officer

  • Mar 2021 - 2 years 10 months



Kensana

• Canada
• Biotechnology Research
• 1 - 100 Employee

• CEO and Board Member

  • Jan 2019 - Feb 2021

  A Healthcare Agri- Biotech Company with daughter companies in Germany, Australia, Israel & Canada.  Management of an International Company.  Raised funds.  Built the strategy ,business opportunity and implementation tactics.  Secured an array of strategic agreements from R&D investment to sales & distribution.



Syqe Medical

• Israel
• Biotechnology Research
• 1 - 100 Employee

• General Manager

  • Feb 2014 - Dec 2018

  Tel Aviv Area, Israel  Managed to signifcantly increase valuation in a completely new medical field.  Built business plan & implemented the company's strategic and operational structure.  Led round of fundraising with total amount invested in double - digit M$  Successfully negotiated strategic agreements with a fortune 100 and 500 companies.  Managed to update and change regulatory pathway and approvals.



JMA

• Consultant & Private Entrepreneur

  • Nov 2011 - Jan 2014

   Cross boarder M&A in Healthcare.  Consulting Healthcare startup companies on strategy/business plans/development and selective fund raising includ. Exim banks.  Business Development opportunities Internationally.  Entrepreneurship in Sri Lanka and India such as aquaculture, Agriculture, Key construction projects, Desalination, Green energy etc.



Perrigo Company plc

• Ireland
• Manufacturing
• 700 & Above Employee

• VP Business Development

  • Oct 2007 - Oct 2011

   Member of the Israeli Corporate management team(NASDAQ & TLV TRADED).  On the Management team of 2 Companies.  Responsible for Strategy, M&A, JV’s and strategic collaborations.  Responsible for finding companies/products to represent/sell.  In depth knowledge and connections in India.  Worldwide network of investment bankers.  Successful M&A in India, Europe & Israel.



Schering-Plough

• Business Unit Manager & Regional Manager

  • 2002 - 2007

  Regional Marketing Leader (22 country) CEE - product field.  Experienced in working in global matrixes(reported into 3 different managers).  Member of Global Brand Team (GBT), defining global brand strategy.  A Member of the Global "Talent Pool".  Member of the local country management team.  Managed 2 sales & marketing teams grew sales X3.  Manager in a joint venture team with Merck.



Dexcel Pharma

• Israel
• Pharmaceutical Manufacturing
• 300 - 400 Employee

• Export Manager

  • 1998 - 2000

   Grew regional sales from single digit to double digit(3X).  Opened the US subsidiary & Managed the UK subsidiary.  European licensing customers included Novartis, Alpharma.  Managed company’s first off-patent European product introduction.  After an acquisition cancelled licensing agreement with P&G. Planned and executed the transition including new sales and marketing plan for the innovative product.



Teva Pharmaceuticals

• Israel
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Industrial Engineer followed by Project Manager in Marketing, Ethical, Division

  • 1993 - 1998

  Petaẖ Tiqwa, Central, Israel  Responsible for on going quarterly report on competitive analysis.  Responsible for company market research including relations with external market research consultants.  Responsible for business & operational plans analysis.  Coordinated joint venture activities in a matrix framework.  Member of team that created a process for Teva to analyse and plan future products portfolio 7-10 years before the potential product launch, Managed the process for the division… Show more  Responsible for on going quarterly report on competitive analysis.  Responsible for company market research including relations with external market research consultants.  Responsible for business & operational plans analysis.  Coordinated joint venture activities in a matrix framework.  Member of team that created a process for Teva to analyse and plan future products portfolio 7-10 years before the potential product launch, Managed the process for the division.  Reviewed lab QA processes and managed the implementation of recommendations; which resulted in a reduction of QA release time from an average 5 days to a maximum of 24 hours, a cost savings of approximately $2.5M dollars per year.  Administrative manger, chemical laboratory - staff of 20. Show less